Pharma-Bio Serv (PBSV) Accounts Payables (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Accounts Payables for 16 consecutive years, with $978541.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 4.33% year-over-year to $978541.0; the trailing twelve-month figure through Apr 2026 stood at $978541.0 (up 4.33% YoY), and the FY2025 full-year result was $991169.0, down 12.1% from the prior year.
• Accounts Payables grew to $978541.0 in Q2 2026 per PBSV's latest filing, from $869964.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $1.7 million in Q3 2022 and bottomed at $869964.0 in Q1 2026.
• Historically, Accounts Payables has averaged $1.3 million across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Accounts Payables tumbled 33.78% in 2024, then increased 4.33% in 2026.
• Over 5 years, Accounts Payables stood at $1.6 million in 2022, then declined by 9.95% to $1.5 million in 2023, then retreated by 23.15% to $1.1 million in 2024, then decreased by 12.1% to $991169.0 in 2025, then slipped by 1.27% to $978541.0 in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $978541.0, $869964.0, and $991169.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.